Medical device major Boston Scientific Corporation BSX recently commercially launched its Vercise Primary Cell (PC) Deep Brain Stimulation (DBS) System in the European markets following the receipt of ...

Medical device major Boston Scientific Corporation BSX recently won CE mark for its Vercise Gevia Deep Brain Stimulation (DBS) System. It is a rechargeable, magnetic resonance (MR) conditional device ...

Medical devices manufacturer Boston Scientific is set to expand its presence in the neurological surgery market, having recently received CE approval for its Vercise Primary Cell Deep Brain ...

Boston Scientific Corporation BSX recently received FDA approval for its ImageReady MRI labeling for the Vercise Gevia Deep Brain Stimulation (DBS) system. The system, to be used in a full-body ...

All 40 participants underwent successful implantation of the Vercise DBS System. The Vercise DBS System demonstrated a significant improvement in motor function (p<0.0001), as assessed by UPDRS III (1 ...

Boston Scientific is launching a new clinical trial to develop its Vercise DBS system.--Courtesy of Boston Scientific Boston Scientific ($BSX) is ramping up ...

Medical device major Boston Scientific CorporationBSX recently won CE mark for its Vercise Gevia Deep Brain Stimulation (DBS) System. It is a rechargeable, magnetic resonance (MR) conditional device ...